Form

Form is Bowery Clinic’s body-composition and metabolic wellness troche combining Tesamorelin, Ipamorelin, AOD-9604, and MOTS-c. The blend brings together four different research pathways: Tesamorelin and Ipamorelin influence growth-hormone signaling, AOD-9604 was developed from a lipolytic region of growth hormone, and MOTS-c is a mitochondrial-derived peptide studied for metabolic homeostasis. Human research shows that Tesamorelin can reduce visceral adipose tissue in studied populations clinical trial, Ipamorelin stimulates growth-hormone release in human volunteers human study, and MOTS-c has strong preclinical metabolic data research.

Form is intended to support body-composition and metabolic goals through several complementary mechanisms. Tesamorelin stimulates endogenous growth-hormone release and has human data showing reductions in visceral fat and favorable changes in some metabolic measures research. Ipamorelin is a growth-hormone secretagogue with human pharmacodynamic data study. AOD-9604 was designed to isolate part of growth hormone’s fat-metabolism activity preclinical research, while MOTS-c is linked to AMPK and mitochondrial metabolic signaling research. The goal is to support fat distribution, metabolic efficiency, and body composition alongside nutrition and resistance training—not to promise rapid weight loss.

Form should be used only after a clinician reviews the patient’s metabolic and endocrine history. Several ingredients influence growth-hormone or metabolic signaling, so the protocol may not be appropriate for every patient, particularly when there are concerns involving glucose regulation, active malignancy, pregnancy, pituitary disease, or concurrent hormone therapies. Your clinician will review other medications and peptide use to avoid stacking overlapping growth-hormone-axis therapies without a clear plan. Any persistent swelling, headache, tingling, glucose-related symptoms, or other unexpected effect should prompt clinical review.

Form should be evaluated over at least 8–12 weeks for body-composition goals. Energy, recovery, or sleep-related changes may be noticed within the first 2–4 weeks, while changes in waist measurements, fat distribution, or lean mass generally require several months of consistent treatment, nutrition, and training. Fuller progress is better assessed around 3–6 months.

Bowery Clinic peptides are higher-strength and clinically dosed compared to most research facilities that use much lower concentrations. They are compounded by licensed 503A pharmacies with physician oversight and sterile quality standards, prioritizing real therapeutic outcomes over cheaper, unregulated research-grade products, and come fully prepared and ready for use — no mixing or reconstitution needed.

Yes. All pharmacies in our network are fully licensed in the states where they operate and comply with all state board of pharmacy regulations. Unlike many peptide clinics, we partner exclusively with FDA-registered U.S. pharmacies that undergo rigorous evaluation and compliance checks.

Every patient receives treatment plans developed and monitored by licensed providers. This includes safe titration of dosages and ongoing medical oversight tailored to individual needs.

Injections deliver the medication directly into your system. This makes the absorption more consistent and effective. Troches are small dissolvable lozenges that sit in your mouth until they melt, slowly releasing medication through the lining of your cheek or under your tongue.